Patents by Inventor Abraham B. Woldu

Abraham B. Woldu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for the treatment of diabetes
    Patent number: 11576894
    Abstract: The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is further directed to pharmaceutical compositions for the co-therapy and methods described herein.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: February 14, 2023
    Assignee: Janssen Pharmaceutica NV
    Inventors: Yin Liang, John Ryan, Abraham B. Woldu, Lisa Wu
  • COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
    Publication number: 20170128414
    Abstract: The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is further directed to pharmaceutical compositions for the co-therapy and methods described herein.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Inventors: Yin Liang, John Ryan, Abraham B. Woldu, Lisa Wu
  • COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
    Publication number: 20160089360
    Abstract: The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is further directed to pharmaceutical compositions for the co-therapy and methods described herein.
    Type: Application
    Filed: December 10, 2015
    Publication date: March 31, 2016
    Inventors: Yin Liang, John Ryan, Abraham B. Woldu, Lisa Wu
  • COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
    Publication number: 20150011485
    Abstract: The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is further directed to pharmaceutical compositions for the co-therapy and methods described herein.
    Type: Application
    Filed: August 6, 2014
    Publication date: January 8, 2015
    Inventors: Yin Liang, John Ryan, Abraham B. Woldu, Lisa Wu
  • PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS WITH ATORVASTATIN
    Publication number: 20140248345
    Abstract: This invention relates to a bilayer pharmaceutical compositions comprising fixed-dose combinations of a dipeptidyl peptidase-4 inhibitor and atorvastatin, or a pharmaceutically acceptable salt thereof, methods of preparing such pharmaceutical compositions, and methods of treating Type 2 diabetes with such pharmaceutical compositions.
    Type: Application
    Filed: October 20, 2012
    Publication date: September 4, 2014
    Inventors: Sutthilug Sotthivirat, Edward J. Fagan, Katherine H. Chin, Abraham B. Woldu, Charles DeLuca, Decheng Ma, Walter R. Wasylaschuk, Bhagwant Rege
  • COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
    Publication number: 20110009347
    Abstract: The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is further directed to pharmaceutical compositions for the co-therapy and methods described herein.
    Type: Application
    Filed: July 6, 2010
    Publication date: January 13, 2011
    Inventors: Yin Liang, John Ryan, Abraham B. Woldu, Lisa Wu